RCMT Stock Analysis: RCM Technologies | NASDAQ

Conglomerates | NASDAQ, USA | Market Cap: 289m USD | 12M Return: 50.5% | US7493604000 | Charts, Fundamentals & Technical Analysis

Total Rating 73
Safety 91
Buy Signal 1.80
Conglomerates
Industry Rotation: +1.0
Market Cap: 289M
Avg Turnover: 3.15M
Risk 3d forecast
Volatility42.1%
VaR 5th Pctl6.01%
VaR vs Median-10.4%
Reward TTM
Sharpe Ratio0.91
Rel. Str. IBD96.9
Rel. Str. Peer Group95.2
Character TTM
Beta1.136
Beta Downside0.248
Hurst Exponent0.643
Drawdowns 3y
Max DD53.15%
CAGR/Max DD0.53
CAGR/Mean DD1.07
EPS (Earnings per Share) EPS (Earnings per Share) of RCMT over the last years for every Quarter: "2021-09": 0.1, "2021-12": 0.41, "2022-03": 0.62, "2022-06": 0.57, "2022-09": 0.31, "2022-12": 0.47, "2023-03": 0.44, "2023-06": 0.46, "2023-09": 0.45, "2023-12": 0.65, "2024-03": 0.53, "2024-06": 0.56, "2024-09": 0.44, "2024-12": 0.37, "2025-03": 0.63, "2025-06": 0.69, "2025-09": 0.3, "2025-12": 0.77, "2026-03": 0.69, "2026-06": 0.68,
EPS CAGR: 7.99%
EPS Trend: 71.5%
Last SUE: 1.31
Qual. Beats: 1
Revenue Revenue of RCMT over the last years for every Quarter: 2021-09: 45.471, 2021-12: 64.922, 2022-03: 81.961, 2022-06: 74.346, 2022-09: 58.152, 2022-12: 70.221, 2023-03: 67.124, 2023-06: 67.035, 2023-09: 58.049, 2023-12: 71.028, 2024-03: 71.939, 2024-06: 69.164, 2024-09: 60.365, 2024-12: 76.912, 2025-03: 84.473, 2025-06: 78.166, 2025-09: 70.289, 2025-12: 86.476, 2026-03: 83.038, 2026-06: 93.816,
Rev. CAGR: 9.65%
Rev. Trend: 97.9%
Last SUE: 2.30
Qual. Beats: 1

Warnings

No concerns identified

Tailwinds

Shakeout
Supp Ema20
Rs Leader
Idiosyncratic Leader
Confidence

Seasonality

Not enough history
Description: RCMT RCM Technologies
RCM Technologies, Inc. engages in the provision of business and technology solutions in the United States, Canada, Puerto Rico, Europe, and Philippines. The company operates through three segments: Engineering; Specialty Health Care; and Life Sciences, Data and Solutions (LS&D). It offers engineering services, including project management engineering, integrated design engineering, transmission and distribution power delivery, engineering analysis, engineering-procurement-construction, configuration management, hardware/software validation and verification, quality assurance, technical writing and publications, manufacturing process planning and improvement, and 3D/BIM integrated design. The company also provides long-term and short-term staffing, executive search, international recruitment, and placement solutions in the fields of allied and therapy staffing, correctional healthcare staffing, health information management, nursing services, physician and advanced practice, school staffing and recruitment, and telepractice. In addition, it offers enterprise business solutions, application development and support, IT infrastructure deployment and management, data solutions, digitization, human capital management solutions, as well as technology and business solutions for the life sciences industry and other specific verticals. The company serves aerospace/defense, educational institutions, energy, financial services, healthcare, life sciences, manufacturing and distribution, public sector, and technology. RCM Technologies, Inc. was incorporated in 1971 and is based in Pennsauken, New Jersey.
Headlines to Watch Out For
Piotroski VR-10 (Strict) 6.5
Net Income: 17.1m TTM > 0 and > 6% of Revenue
FCF/TA: 0.17 > 0.02 and ΔFCF/TA 16.74 > 1.0
NWC/Revenue: 14.44% < 20% (prev 15.41%; Δ -0.97% < -1%)
CFO/TA 0.18 > 3% & CFO 23.7m > Net Income 17.1m
Net Debt (23.8m) to EBITDA (28.0m): 0.85 < 3
Current Ratio: 1.92 > 1.5 & < 3
Outstanding Shares: last quarter (7.61m) vs 12m ago 1.02% < -2%
Gross Margin: 26.59% > 18% (prev 27.62%; Δ -1.03% > 0.5%)
Asset Turnover: 247.5% > 50% (prev 221.2%; Δ 26.30% > 0%)
Interest Coverage Ratio: 9.42 > 6 (EBIT TTM 25.8m / Interest Expense TTM 2.74m)
Altman Z'' 4.71
A: 0.36 (Total Current Assets 100.4m - Total Current Liabilities 52.2m) / Total Assets 134.0m
B: 0.14 (Retained Earnings 19.1m / Total Assets 134.0m)
C: 0.19 (EBIT TTM 25.8m / Avg Total Assets 134.8m)
D: 0.57 (Book Value of Equity 48.8m / Total Liabilities 85.2m)
Altman-Z'' = 4.71 = AA
Beneish M -3.02
DSRI: 0.87 (Receivables 88.1m/91.2m, Revenue 333.6m/299.9m)
GMI: 1.04 (GM 27.62% / 26.59%)
AQI: 1.01 (AQ_t 0.17 / AQ_t-1 0.17)
SGI: 1.11 (Revenue 333.6m / 299.9m)
TATA: -0.05 (NI 17.1m - CFO 23.7m) / TA 134.0m)
Beneish M = -3.02 (Cap -4..+1) = AA
What is the price of RCMT shares?

As of September 10, 2026, the stock is trading at USD 40.29 with a total of 63,430 shares traded. Over the past week, the price has changed by -3.89%, over one month by +39.32%, over three months by +65.80% and over the past year by +50.50%.

Current recommended Stop Loss: 38.10 (which is 5.4% or 1.4 ATR below the current price).

Is RCMT a buy, sell or hold?

RCM Technologies has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy RCMT.

  • StrongBuy: 2
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the RCMT price?
Analysts Target Price 45 11.7%
RCM Technologies (RCMT) - Fundamental Data Overview as of 10 September 2026
Market Cap USD = 288.8m (288.8m USD * 1.0 USD.USD)
P/E Trailing = 17.5844
P/E Forward = 12.8041
P/S = 0.8658
P/B = 5.9438
P/EG = 1.36
Revenue TTM = 333.6m USD
EBIT TTM = 25.8m USD
EBITDA TTM = 28.0m USD
Long Term Debt = 23.4m USD (from longTermDebt, last quarter)
Short Term Debt = 1.14m USD (from shortTermDebt, last quarter)
Debt = 30.4m USD (corrected: LT Debt 23.4m + ST Debt 1.14m) + Leases 5.84m
Net Debt = 23.8m USD (calculated: Debt 30.4m - CCE 6.58m)
Enterprise Value = 312.6m USD (288.8m + Debt 30.4m - CCE 6.58m)
Interest Coverage Ratio = 9.42 (Ebit TTM 25.8m / Interest Expense TTM 2.74m)
EV/FCF = 13.70x (Enterprise Value 312.6m / FCF TTM 22.8m)
FCF Yield = 7.30% (FCF TTM 22.8m / Enterprise Value 312.6m)
FCF Margin = 6.84% (FCF TTM 22.8m / Revenue TTM 333.6m)
Net Margin = 5.13% (Net Income TTM 17.1m / Revenue TTM 333.6m)
Gross Margin = 26.59% ((Revenue TTM 333.6m - Cost of Revenue TTM 244.9m) / Revenue TTM)
Gross Margin QoQ = 25.67% (prev 25.85%)
Tobins Q-Ratio = 2.33 (Enterprise Value 312.6m / Total Assets 134.0m)
Interest Expense / Debt = 9.02% (Interest Expense 2.74m / Debt 30.4m)
Taxrate = 25.97% (6.00m / 23.1m)
NOPAT = 19.1m (EBIT 25.8m * (1 - 25.97%))
Current Ratio = 1.92 (Total Current Assets 100.4m / Total Current Liabilities 52.2m)
Debt / Equity = 0.62 (Debt 30.4m / totalStockholderEquity, last quarter 48.8m)
Debt / EBITDA = 0.85 (Net Debt 23.8m / EBITDA 28.0m)
Debt / FCF = 1.04 (Net Debt 23.8m / FCF TTM 22.8m)
Total Stockholder Equity = 45.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.69% (Net Income 17.1m / Total Assets 134.0m)
RoE = 37.92% (Net Income TTM 17.1m / Total Stockholder Equity 45.1m)
RoCE = 37.67% (EBIT 25.8m / Capital Employed (Equity 45.1m + L.T.Debt 23.4m))
RoIC = 25.01% (NOPAT 19.1m / Invested Capital 76.4m)
WACC = 9.67% (E(288.8m)/V(319.2m) * Re(9.98%) + D(30.4m)/V(319.2m) * Rd(9.02%) * (1-Tc(0.26)))
Discount Rate = 9.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -84.05 | Cagr: -3.08%
[DCF] Terminal Value 73.83% ; FCFF base≈13.9m ; Y1≈15.9m ; Y5≈23.4m
[DCF] Fair Price = 36.81 (EV 285.5m - Net Debt 23.8m = Equity 261.7m / Shares 7.11m; r=9.67% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 71.50 | EPS CAGR: 7.99% | SUE: 1.31 | # QB: 1
Revenue Correlation: 97.92 | Revenue CAGR: 9.65% | SUE: 2.30 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.55 | Chg30d=+19.57% | Revisions=+25% | Analysts=2
EPS current Year (2026-12-31): EPS=2.96 | Chg30d=+7.85% | Revisions=+25% | GrowthEPS=+18.2% | GrowthRev=+11.5%
EPS next Year (2027-12-31): EPS=3.27 | Chg30d=+3.00% | Revisions=+25% | GrowthEPS=+10.5% | GrowthRev=+10.1%
[Analyst] Revisions Ratio: +50% (up=3, down=0)